en English

The Pharmacy Hub

The Pharmacy Hub at GenderGP provides pharmacies and chemists with all of the relevant information need for dispensing medication to your transgender customers.

Together We Will Provide World Leading Trans Healthcare With the Pharmacy Hub


In order to ensure our service users get access to the best standards of care, we work with pharmacists who are regulated in their country and who can ensure the medication they dispense is legitimate and safe. This is all achievable with use of our pharmacy hub.

The Pharmacy Hub section of our website aims to inform our pharmacy colleagues about our approach and provide any reassurance, should it be needed, about the role they can play in providing care to this population.

If you believe that trans patients should be able to access safe, effective, well-led, responsive care, and you would like to join our network of pharmacies to receive direct referrals from us, please leave us your details and become a trusted partner at The Pharmacy Hub.

Verify our Prescribers

Contact The Pharmacy Hub

Join our Pharmacy Network

Trans Healthcare
Risk assessment and management
How GenderGP operates
GPhC Guidance

Pharmacy FAQs

Testosterone is considered as a Class C, Schedule 4 Part2 controlled drug because it is in the same class as anabolic steroids which have been open to abuse because of their body enhancing properties.

There has historically been some concern by pharmacists that they are not allowed to dispense controlled drugs against an EU prescription, however the British National Formulary (BNF) gives very clear guidance on prescribing and dispensing laws in the UK and it advises:

Schedule 4 Part II includes androgenic and anabolic steroids, clenbuterol, chorionic gonadotrophin (HCG), non-human chorionic gonadotrophin, somatotropin, somatrem, and somatropin. Controlled drug prescription requirements do not apply and Schedule 4 Controlled Drugs are not subject to safe custody requirements.

Testosterone used to achieve masculinisation in trans masculine people is a core part of the medication used for medical transition. Used in this context it is a safe and well evaluated aspect of gender-affirming care.

If you have any concerns please complete the following form and a member of the team will contact you.

Incident reporting here: https://www.gendergp.com/ask-gendergp-pharmacists/

Safeguarding here: https://www.gendergp.com/pharmacy-safeguarding/

All decisions are made by a multidisciplinary team which includes several doctors. If you would like details of the specific doctor related to a specific patient then, you can request that information here.

A lack of education and awareness around trans issues has led to a culture of fear. This hampers safe and effective provision of care for this patient group. Active anti-trans lobbyists have raised unnecessary and unfounded concerns, particularly in relation to trans youth, and this has made regulators very concerned. Although this concern appears in other countries, it seems that the UK is falling behind in understanding the need for equality in healthcare for trans patients.

We are a global, online Health and Wellbeing service for transgender people. All of our medical and professional team are regulated to carry out their services in their country of residence. We are owned by Harland International Ltd and trade as GenderGP. Full details are available on request.

In recent years, understanding around what it means to be transgender has increased significantly. This has led to many more people stepping forward and asking for help with their social, medical and legal transition. In many countries, medical services have failed to keep up with demand, with too few healthcare professionals feeling able, or willing to help. A reluctance all too often driven by social, medical and political prejudice. These factors have also driven the wider narrative on trans healthcare with very strong opinions coming to the fore from prominent figures who do not support the notion that trans people exist, much less that they should be affirmed.

Yes! The NHS has a legal duty to provide this care. While the UK is falling behind in its provision to the trans community and specifically trans youth, leading centres of excellence worldwide have issued clear guidance in recent years which promotes the benefits of affirmative care. At GenderGP we follow this best practice to ensure all trans individuals, wherever they are in the world and however old they are, have access to the care they need.

In December, a high court ruling determined that it was unlikely that those under the age of 16 could consent to treatment. There has been much controversy surrounding the case and the Tavistock and Portman clinic (the only NHS provider of care to trans youth) has since been granted an appeal. This is due to take place in June 2021. We have compiled the following resource for anyone wishing to better understand the implications of the ruling. Sadly, there are many trans people of all ages who do not have the support of their parents or loved ones. For these individuals we take the same stance on consent as the NHS.

Dr Helen Webberley is the founder of GenderGP she continues to campaign tirelessly for improvements in trans healthcare, she is not currently practising as a GP. If you would like to read more about Dr Helen you can do so here.

Leading experts worldwide agree that: “[puberty suppression and subsequent gender affirming hormones] is the most widely accepted and preferred clinical approach in health services for transgender people around the world.”

Absolutely. You can see our reviews on both Trustpilot and Google and the testimonials page of the GenderGP website.

Yes you can. Please click on this link to view our template SLA.

It is well known that many medications that are prescribed are unlicensed for use in trans healthcare. You can read GMC guidance about this here and GPhC advice here. All of our clinicians prescribe in line with The Endocrine Society Guidelines for the Care of Transgender Patients. Our prescribing protocol and a list of prescribed medications can be found here.

Yes. All of our doctors have been carefully selected for their knowledge, skills and attitude in the field of gender-related healthcare and they follow strict International guidance for treatment protocols. Doctors working with GenderGP support thousands of patients in their capacity as gender specialists.

There is no recognised training or qualification in this field, so all learning is by personal professional development. GenderGP and its doctors follow the peer-reviewed, published International Guidance from the WPATH, The Endocrine Society, The University of California, San Francisco (UCSF) and Australia. Find out more here.

Yes, there are plenty of things you can do including the provision of training to your pharmacy team to ensure their approach is inclusive visit: https://lgbt.foundation/prideinpractice to find out more. You can also sign up to our pharmacy network here.

There is currently no specific training available which relates to this group of patients. The medication used and the monitoring required within this patient group, is no different to those who are being treated for menopause, endometriosis, prostate cancer, precocious puberty, constitutional delay in puberty.

Gender dysphoria is not a highly specialised field that involves dangerous medication requiring comprehensive monitoring. The benefits of having access to care far outweigh the risks associated with the denial of that care, particularly in light of NHS waiting times that are in breach of the NHS constitution.

In balancing the risks of providing essential pharmacy services to this patient cohort, there must also be an analysis of the risk of not providing services. Patients who struggle to get access to medical and pharmaceutical healthcare services often turn to the grey or black market.

Yes. Please complete the following form and a member of the team will contact you.

GenderGP is a global organisation which provides health and wellbeing services to transgender people and those who care for them. Our organisation comprises medical and therapeutic gender specialists from all over the world who are regulated in each area of their specialism in the countries in which they are based.

As an international organisation we are not bound by English regulators. However, all of our specialists are individually regulated for each of the activities they carry out in the countries in which they are professionally registered.

At GenderGP we take the safeguarding of all patients very seriously. Our safeguarding statement and policies can be accessed here.

Capacity is obtained via written and verbal communication for all patients. Anyone who is over the age of 16 can be presumed to be able to have the capacity to consent to their own medical treatment unless concerns are raised. Anyone under the age of 16 can consent to their own treatment, as long as they are able to show that they can understand the implications of that treatment. Of course there will be people who are over 16 who will be unable to understand and make decisions, just as there will be people under 16 who are unable to consent. A full overview of our approach to consent can be found here.

Our team of gender specialists carry out personal, physical, social, gender assessments according to need. We adopt a multidisciplinary approach. We do not believe in putting people through mandatory lengthy assessments in order to validate their gender. People who come to us understand their own experience better than anyone, our role is to help them to begin – or continue – their journey. We simply work with our service users to gather key information so that we understand more about them and their transition goals and our medical team can recommend the best course of action. You can read more about our approach to assessments here.